Figure 9From: Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicityER status and subgroup survival trends. Compared to the 30% disparity in survival between ethnicity groups for all tumor types (Figure 6), disparities decrease to 10% in the ER positive tumor category (top) and increases to 40% (bottom) in the ER negative tumor category. While both ethnic groups show a lower survival rate in ER negative tumor groups, the survival is far worse in the African American group.Back to article page